Serious Adverse Event episodes (in 2-year period)
| |
Dolan
|
Shaw
|
Brazier SF6D (SF12)
|
Brazier SF6D (SF36)
|
Lundberg
|
Lawrence
|
Franks MEPS
|
Franks
|
Fryback
|
---|
NO
|
Mean difference*
|
-.024
|
-.017
|
-.019
|
-.019
|
-.021
|
-.023
|
-.022
|
-.018
|
-.013
|
|
Std. Deviation
|
.196
|
.139
|
.115
|
.121
|
.078
|
.142
|
.146
|
.146
|
.068
|
YES
|
Mean difference*
|
-.042
|
-.028
|
-.035
|
-.031
|
-.037
|
-.046
|
-.052
|
-.058
|
-.015
|
|
Std. Deviation
|
.230
|
.157
|
.127
|
.125
|
.087
|
.156
|
.173
|
.190
|
.068
|
Regression coeff** (P value)
|
-.040 (.003)
|
-.028 (.003)
|
-.033 (<.001)
|
-.032 (<.001)
|
-.024 (<.001)
|
-.046 (<.001)
|
-.053 (<.001)
|
-.062 (<.001)
|
-.017 (<.001)
|
Signal/Noise ratio
|
.090
|
.082
|
.136
|
.104
|
.202
|
.161
|
.205
|
.277
|
.037
|
- Note1: * Mean difference is the mean of the difference between the two-year and baseline values for each utility measure.
- Note2: ** Regression model assessed significance of Serious Adverse Event episodes on difference in 2 yr score, adjusted for baseline score.